Evidence map›Paper›PMID 42323477›Full record

ArticleScientific reports2026

Neuron-specific expression of transmembrane protein 130 (TMEM130).

Tomomichi Kayahara, Masahiko Itani, Hiroki Kurita, Tomohiro Aoki

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tomomichi KayaharaDepartment of Cerebrovascular Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, 350-1298, Saitama, Japan. t_kayahara@saitama-med.ac.jp.
Masahiko ItaniDepartment of Pharmacology, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
Hiroki KuritaDepartment of Cerebrovascular Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, 350-1298, Saitama, Japan.
Tomohiro AokiDepartment of Pharmacology, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.

Funding

a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology 20K09381a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology 21K16622Grants from the Jikei University School of Medicine 2025-101-SS
6 · The paper itself

Abstract

Transmembrane protein 130 (TMEM130) was identified as significantly downregulated in rupture-prone intracranial aneurysm lesions in a rat model. This study aimed to characterize TMEM130 tissue distribution and physiological function in rats. RNA sequencing was conducted on rupture-prone intracranial aneurysm lesions and control arterial tissues to identify differentially expressed genes. Tmem130 mRNA spatial expression patterns were examined by in situ hybridization across multiple rat organs. A Tmem130-deficient rat line was generated using the CRISPR-Cas9 system to evaluate potential functional effects. Histological analyses and open-field behavioral tests were performed to assess neuronal morphology and locomotor or anxiety-like behavior, respectively. In situ hybridization revealed that Tmem130 expression was restricted to the brain and adrenal medulla, with widespread localization in neurons throughout cortical and subcortical regions. Here, TMEM130 was detected only in transcriptional level due to the absence of TMEM130-specific antibody. Tmem130

Indexed as

Membrane ProteinsNeuronsAnimalsBrainMaleRatsMembrane ProteinsAdrenal glandBrainIntracranial aneurysmNeuronTransmembrane protein 130

Identifiers

PMID42323477
PMCPMC13558750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.